Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2)Jean Reignier, Danièle Combaux, Julie Helms et al.|The Lancet|2017Cited by 568
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trialPierre‐François Laterre, Anne-Aurore Duchambon, Oliver Hartmann et al.|Intensive Care Medicine|2021Cited by 92
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)Jatin Patel, Mark Layton, Damon Bass et al.|European Respiratory Journal|2022Cited by 42
Invasive group A streptococcal infections requiring admission to ICU: a nationwide, multicenter, retrospective study (ISTRE study)Arthur Orieux, Renaud Prével, Margot Dumery et al.|Critical Care|2024Cited by 32
A Randomized Trial of Otilimab in Severe COVID-19 Pneumonia (OSCAR)Jatin Patel, Mark Layton, Albertus Beishuizen et al.|medRxiv|2021Cited by 27